CancerDrs Find care

Kidney Cancer clinical trials in Nevada

9 actively recruiting kidney cancer trials at 5 sites across Nevada.

Data from ClinicalTrials.gov · last refreshed

Phase 2, Phase 3 Recruiting NIH

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment called immunotherapy to help prevent their urinary tract (urothelial) cancer f…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT05987241
Sites in Nevada:
  • OptumCare Cancer Care at Seven Hills — Henderson, Nevada
  • OptumCare Cancer Care at Charleston — Las Vegas, Nevada
  • OptumCare Cancer Care at Fort Apache — Las Vegas, Nevada
View on ClinicalTrials.gov →
Phase 3 Recruiting Network

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spr…

Sponsor: SWOG Cancer Research Network
NCT ID: NCT04510597
Sites in Nevada:
  • Carson Tahoe Regional Medical Center — Carson City, Nevada
  • Cancer and Blood Specialists-Henderson — Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada-Horizon Ridge — Henderson, Nevada
  • Las Vegas Cancer Center-Henderson — Henderson, Nevada
View on ClinicalTrials.gov →
Phase 3 Recruiting Academic/Other

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radia…

Sponsor: NRG Oncology
NCT ID: NCT06500455
Sites in Nevada:
  • Renown Regional Medical Center — Reno, Nevada
View on ClinicalTrials.gov →
Phase 2 Recruiting NIH

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT03866382
Sites in Nevada:
  • Carson Tahoe Regional Medical Center — Carson City, Nevada
  • Cancer and Blood Specialists-Henderson — Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada-Horizon Ridge — Henderson, Nevada
  • Las Vegas Cancer Center-Henderson — Henderson, Nevada
View on ClinicalTrials.gov →
Phase 2 Recruiting Network

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

This phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Dru…

Sponsor: Children's Oncology Group
NCT ID: NCT04322318
Sites in Nevada:
  • University Medical Center of Southern Nevada — Las Vegas, Nevada
  • Sunrise Hospital and Medical Center — Las Vegas, Nevada
  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation — Las Vegas, Nevada
  • Summerlin Hospital Medical Center — Las Vegas, Nevada
  • Renown Regional Medical Center — Reno, Nevada
View on ClinicalTrials.gov →
Phase 1 Recruiting Industry

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity, and effect of biomarkers of zanzalintinib administered alon…

Sponsor: Exelixis
NCT ID: NCT05176483
Sites in Nevada:
  • Exelixis Clinical Site #55 — Las Vegas, Nevada
View on ClinicalTrials.gov →
Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT05334069
Sites in Nevada:
  • Carson Tahoe Regional Medical Center — Carson City, Nevada
  • Cancer and Blood Specialists-Henderson — Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada-Horizon Ridge — Henderson, Nevada
  • Las Vegas Cancer Center-Henderson — Henderson, Nevada
View on ClinicalTrials.gov →
Recruiting Network

Project: Every Child for Younger Patients With Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going ca…

Sponsor: Children's Oncology Group
NCT ID: NCT02402244
Sites in Nevada:
  • Las Vegas Urology - Pebble — Henderson, Nevada
  • Oncology Las Vegas - Henderson — Henderson, Nevada
  • Las Vegas Urology - Pecos — Las Vegas, Nevada
  • University Medical Center of Southern Nevada — Las Vegas, Nevada
  • Sunrise Hospital and Medical Center — Las Vegas, Nevada
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20